FindTrial
Sign In

Analysis of positive results of 18F-FDG PET/CT imaging after hematopoietic stem cell transplantation in lymphoma

Analysis of positive results of 18F-FDG PET/CT imaging after hematopoietic stem cell transplantation in lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067355
Enrollment
Unknown
Registered
2023-01-05
Start date
2023-01-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

None listed

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: Institutional databases were reviewed to identify patients with lymphoma who met the following inclusion criteria: all histologic types of NHL were allowed as well as HL, HSCT between January 2013 and December 2020 in our institution, and post-transplantation [18F] F-FDG PET/CT scans after HSCT.

Exclusion criteria

Exclusion criteria: 1. Received systemic therapy for lymphoma on day 0 of transplantation and within the time window of post-transplantation PET, but not including maintenance therapy; 2. Patients lost to follow-up.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression-free survival;—

Secondary

MeasureTime frame
PET Deauville score;size of lesion;—

Countries

China

Contacts

Public ContactNa Dai

The First Affiliated Hospital of Soochow University

dnsundaysong@163.com+86 137 7179 3585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026